VCEL · Healthcare · $2.1B
$40.14-1.16%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“MACI(무릎 연골 치료제)가 이번 분기에도 22% 성장하며 역대 1분기 최고 매출을 기록했어요.”
In the company's words · 2026 1분기 earnings call